School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Simulations Plus Inc SLP

Healthcare · Health Care

$18.50last close 2026-10-07 · market cap $374.16M · delayed data

Trailing returns

1M+0.38%
3M+1.20%
6M+46.25%
1Y+12.12%
5Y-52.29%

Basis: Adjusted daily closes.

What it does

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments.

Open SLP in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies